-
Case Report
-
Korean J Med. 2026;101(5):267-271. Published online October 1, 2026.
DOI: https://doi.org/10.3904/kjm.2026.101.5.267
- 피네레논 초기 투여 후 급격한 신기능 악화 증례
-
김정순1, 임홍일2, 이소영1, 김효정3, 정경연3, 김진택3
-
1을지대학교 의과대학 노원을지대학교병원 신장내과
2동국대학교 의과대학 동국대학교경주병원 신장내과
3을지대학교 의과대학 노원을지대학교병원 내분비내과
- Rapid Progression to End-Stage Kidney Disease and Anuria Following Finerenone Initiation in a Patient with Advanced Diabetic Kidney Disease
-
Jung Soon Kim1, Hong Il Lim2, So Young Lee1, Hyo-Jeong Kim3, Kyong Yeun Jung3, Jin Taek Kim3
-
1Division of Nephrology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea
2Division of Nephrology, Department of Internal Medicine, Dongguk University Gyeongju Hospital, Dongguk University School of Medicine, Gyeongju, Korea
3Division of Endocrinology and Metabolism, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea
- Corresponding author: Jung Soon Kim ,Tel: +82-2-970-8619, Fax: +82-2-970-8457, Email: jtkimmd@eulji.ac.kr
- Received: September 8, 2025; Revised: December 16, 2025 Accepted: December 26, 2025.
-
߽ɾ :당뇨병성 신증; 신부전; 무기질코르티코이드 수용체길항제; 신대체 요법
- Abstract
- This case report describes a 70-year-old woman with advanced diabetic kidney disease who developed end-stage kidney disease (ESKD) and complete anuria within seven weeks of initiating finerenone therapy. This case highlights the need for caution when prescribing finerenone to patients with severely impaired renal function, particularly those with minimal residual renal reserve. Clinicians should be vigilant for signs of renal decompensation during the early phases of therapy.
Keywords :Diabetic nephropathies, Renal insufficiency, Mineralocorticoid receptor antagonists, Renal dialysis
